Form 8-K - Current report:
SEC Accession No. 0001104659-23-077539
Filing Date
2023-07-03
Accepted
2023-07-03 13:31:15
Documents
12
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320404d1_8k.htm   iXBRL 8-K 31913
  Complete submission text file 0001104659-23-077539.txt   207690

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aptx-20230630.xsd EX-101.SCH 2956
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20230630_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20230630_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320404d1_8k_htm.xml XML 3743
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

EIN.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 231064524
SIC: 2834 Pharmaceutical Preparations